BOSCO, Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 720
EU - Europa 136
AS - Asia 110
OC - Oceania 1
Totale 967
Nazione #
US - Stati Uniti d'America 720
CN - Cina 75
UA - Ucraina 38
IT - Italia 28
DE - Germania 26
GB - Regno Unito 23
TR - Turchia 22
SG - Singapore 11
FI - Finlandia 9
SE - Svezia 7
FR - Francia 2
NL - Olanda 2
AU - Australia 1
CZ - Repubblica Ceca 1
IN - India 1
JP - Giappone 1
Totale 967
Città #
Fairfield 124
Woodbridge 96
Ashburn 65
Houston 59
Chandler 52
Seattle 51
Jacksonville 46
Cambridge 45
Wilmington 33
Beijing 27
New York 20
Izmir 17
Ferrara 13
San Diego 13
Nanjing 12
Ann Arbor 11
Singapore 10
Princeton 9
Boardman 8
Shanghai 8
Milan 6
Shenyang 5
Bremen 4
Washington 4
Changsha 3
Haikou 3
Auburn Hills 2
Jiaxing 2
Leawood 2
Los Angeles 2
Nanchang 2
Ningbo 2
Orange 2
Padova 2
Tianjin 2
West Lafayette 2
Augusta 1
Bologna 1
Dearborn 1
Hangzhou 1
Hebei 1
Jinan 1
Kunming 1
Lanzhou 1
Linköping 1
Mountain View 1
Norwalk 1
Olomouc 1
Redwood City 1
San Mateo 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Torino 1
Verona 1
Weiden 1
Zhengzhou 1
Totale 785
Nome #
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 126
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 110
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. 109
null 97
null 94
null 92
null 90
null 83
null 76
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 23
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 21
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 20
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 17
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 12
Recent advances in the therapeutic perspectives of Nutlin-3 11
Totale 981
Categoria #
all - tutte 3.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020225 0 9 12 40 18 26 21 28 21 33 14 3
2020/2021139 12 13 2 24 15 11 6 15 3 14 18 6
2021/2022118 2 11 25 3 4 4 8 6 4 6 18 27
2022/2023112 11 12 3 14 17 17 4 5 13 4 8 4
2023/202453 1 7 0 0 0 23 4 1 1 1 2 13
2024/20257 5 2 0 0 0 0 0 0 0 0 0 0
Totale 981